000159501 000__ 01567fam\a2200373\a\4500
000159501 001__ 159501
000159501 005__ 20220217103354.0
000159501 008__ 930609s1993\\\\dcua\\\\\b\\\f000\0\eng\d
000159501 020__ $$a0160408482
000159501 035__ $$a(OCoLC)ocm28237565
000159501 035__ $$9(IS)TVT7528
000159501 035__ $$9AAS6454SI
000159501 035__ $$a159501
000159501 040__ $$aGPO$$cGPO
000159501 043__ $$an-us---
000159501 049__ $$aISUW
000159501 074__ $$a1009-B-01
000159501 0860_ $$aY 4.AG 4:S.HRG.103-50
000159501 088__ $$aSerial no. 103-1 (United States. Congress. Senate. Special Committee on Aging)
000159501 1101_ $$aUnited States.$$bCongress.$$bSenate.$$bSpecial Committee on Aging.
000159501 24514 $$aThe federal government's investment in new drug research and development :$$bare we getting our money's worth? : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Washington, DC, February 24, 1992.
000159501 260__ $$aWashington :$$bU.S. G.P.O. :$$bFor sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,$$c1993.
000159501 300__ $$aiii, 189 p. :$$bill. ;$$c24 cm.
000159501 4901_ $$aS. hrg. ;$$v103-50
000159501 500__ $$aDistributed to some depository libraries in microfiche.
000159501 500__ $$aShipping list no.: 93-0299-P.
000159501 500__ $$a"Serial no. 103-1."
000159501 504__ $$aIncludes bibliographical references.
000159501 650_0 $$aDrugs$$xResearch$$zUnited States$$xFinance.
000159501 650_0 $$aDrugs$$xPrices$$zUnited States.
000159501 650_0 $$aPharmaceutical industry$$zUnited States.
000159501 650_0 $$aPharmaceutical policy$$zUnited States.
000159501 8101_ $$aUnited States.$$bCongress.$$bSenate.$$tS. hrg. ;$$v103-50.
000159501 85230 $$bdfich$$hY 4.AG 4:$$iS.HRG.$$i103-50
000159501 909CO $$ooai:library.usi.edu:159501$$pGLOBAL_SET
000159501 948__ $$ac:pw
000159501 980__ $$aBIB
000159501 980__ $$aGOV RESOURCE